TP53 and non-small cell lung carcinoma: Whether the occurrence of TP53 gene mutation could affect the binding of TP53 with GHRLOS promoter, and hence inducing the loss of function of lncRNA GHRLOS in inhibiting the progression of NSCLC still required to verified.